Roche Holding AG
DUS:RHO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Roche Holding AG
DUS:RHO
|
CH |
|
Fox Corp
F:FO5
|
US |
|
N
|
Nucor Corp
DUS:NUO
|
US |
|
P
|
Pearson PLC
XMUN:PES
|
UK |
|
M
|
MacroAsia Corp
XPHS:MAC
|
PH |
|
Galaxy Entertainment Group Ltd
F:KW9A
|
HK |
|
A
|
Amazon.com Inc
DUS:AMZ
|
US |
|
3
|
3M Co
XHAM:MMM
|
US |
|
C
|
Coca-Cola Europacific Partners PLC
AEX:CCEP
|
UK |
|
M
|
Mitsui & Co Ltd
DUS:MTS1
|
JP |
|
Pliant Therapeutics Inc
NASDAQ:PLRX
|
US |
Wall St Price Targets
RHO Price Targets Summary
Roche Holding AG
According to Wall Street analysts, the average 1-year price target for RHO is 411.26 EUR with a low forecast of 259.83 EUR and a high forecast of 502.67 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RHO's stock price target?
Price Target
411.26
EUR
According to Wall Street analysts, the average 1-year price target for RHO is 411.26 EUR with a low forecast of 259.83 EUR and a high forecast of 502.67 EUR.
What is the Revenue forecast for Roche Holding AG?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Roche Holding AG?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Roche Holding AG?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 14%.
